All In MedTech

Device Trial Radar · NCT07422259

Tolerability and Efficacy Study of Reinnerva/Lubristil+G vs Vismed

Tolerability and Efficacy of Reinnerva/Lubristil+G vs Vismed in the Treatment of the Ocular Surface of Patients With Quali-quantitative Alteration of Lacrimal Film of Different Origins

Last checked: Nov 20, 2026Latest source record: Feb 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

Jun 9, 2025

Primary completion

Sep 3, 2025

Study completion Sep 3, 2025

Sponsor

Lead sponsor
Medivis SRLNot on our public-company list
Sponsor type
Industry
Collaborators
University of Messina
First posted
Feb 19, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The clinical investigation #1122 is a Post Market Clinical Follow Up Study on the EC marked medical device Reinnerva/Lubristil +G, sterile eye drops, compared to Vismed medical device, sterile eye drops, to demonstrate the clinical performance and tolerability of Reinnerva/Lubristil +G to stabilize the lacrimal film and improve the ocular surface condition in the cases of quali-quantitative alterations of the tear film .

Conditions

  • Keratoconjunctivitis Sicca

Interventions

  • Reinnerva/Lubristil +G sterile eye drops (artificial tears)Device

    2 drops instilled in 1 eye, 2 times daily, for 60 days

  • Vismed sterile eye drops (artificial tears)Device

    2 drops instilled in 1 eye, 4 times daily, for 60 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical Performance and BenefitTime frame: From enrollment to the end of treatment at 30 and 60 days.

5 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • UOC of Ophthalmology, AOU Policlinico "G. Martino"

    Messina, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.